Term ends Aug 7, 2043 · High confidence
20-year base term ends Aug 7, 2043
Held by Verona Pharma Limited
Filed Jan 26, 2024 as application 18/424,452 · Granted Sep 15, 2026
Base term, 20 years from filing
Today
2023
2043
Clock starts
Aug 7, 2023
Aug 7, 2023
Term ends
Aug 7, 2043
Aug 7, 2043
Granted
Sep 15, 2026
Sep 15, 2026
base term
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 12,758,511, to Aug 7, 2043. The term already ends on or before that date, so the cap shortened nothing.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 7, 2023, when application PCT/GB2023/052084, the earliest non-provisional in its chain, was filed (this one was filed Jan 26, 2024) | Aug 7, 2043 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 12,758,511) | resolves to Aug 7, 2043, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Aug 7, 2043 | High confidence |
Partial family
| Application PCT/GB2023/052084 | PCT application no patent term | no patent term |
| US 12,734,139 | this patent Aug 2043 | Aug 2043 |
| Application 19/728,578 | Pending not computed | not computed |
Partial: 1 of the 3 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 29, 2024 Reel 66600, frame 400 | Rheault, Tara Renae; Rickard, Kathleen; Bengtsson, Thomas | Verona Pharma PLC | Assignment of Assignor's Interest |
| Mar 25, 2025 Reel 70618, frame 561 | Oaktree Fund Administration, LLC, as Agent | Verona Pharma PLC | Release of Security Interest in Patents at R/F 067387/0799 |
| Oct 7, 2025 Reel 72495, frame 271 | Oaktree Fund Administration, LLC | Verona Pharma PLC | Release of Security Interest |
| Jan 12, 2026 Reel 73534, frame 491 | Verona Pharma PLC | Verona Pharma Limited | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Aug 2043
Term ends Aug 7, 2043. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 12,758,511, ends no earlier than this term, so it caps nothing.
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.